statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gold Down Over 1%; AC Immune Shares Spike Higher

Unlocking hope for Alzheimer's with ACI-24.060. Takeda's agreement with AC Immune targets toxic forms of Abeta, potentially slowing disease progression.
read more...

Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?

Futures Gain With All Time Highs In Sight As Key CPI Report Looms

 US equity futures extended last week's solid gains when they traded just about 1% below all time highs, as investors...

Futures Gain With All Time Highs In Sight As Key CPI Report Looms

Takeda (TSE:4502/NYSE:TAK) and AC Immune SA (NASDAQ: ACIU) today announced an exclusive, worldwide option and license agreement for AC Immunes active immunotherapies targeting toxic forms of amyloid...

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimers Disease

This is a signal that ACIU's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

AC Immune SA (ACIU, $3.46) Stochastic Oscillator left the oversold zone on March 18, 2024

This is a Bearish indicator signaling ACIU's price could decline from here. Traders may explore shorting the stock or put options...

AC Immune SA (ACIU, $3.32) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 14, 2024

This price move could indicate a change in the trend, and may be a sell signal for investors...

AC Immune SA (ACIU, $3.32) price exceeded its 50-day Moving Average on March 14, 2024

AC Immune SA (ACIU, $3.32) Stochastic Oscillator left the oversold zone on March 14, 2024

This price move could be a signal that ACIU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

AC Immune SA (ACIU, $3.32) price may climb as it broke lower Bollinger Band on Mar 14, 2024

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in...

AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Watchers	3,856
52-Wk Low	$1.90
52-Wk High	$5.14

Volume	550,828.00
52-Wk High	$5.14
52-Wk Low	$1.90

Period	Estimated	Reported	Surprise	Result
Q2'24	$0.11	--	--	N/A
Q1'24	-$0.15	-$0.20	-33.82%	MISSED
Q4'23	-$0.11	--	--	N/A
Q3'23	$0.03	-$0.21	-710.98%	MISSED
Q2'23	-$0.23	-$0.23	-3.52%	MISSED

ACIU AC Immune SA

About

Feed

News

Sentiment

Earnings

Fundamentals